Harms v. Abbott Laboratories et al
| Rachell Harms |
| Abbott Laboratories, The Procter & Gamble Distributing LLC F/K/A The Procter & Gamble Distributing Co., Glaxosmithkline Consumer Healthcare Holdings (US) LLC, Novartis Vaccines And Diagnostics, Inc., Takeda Pharmaceuticals USA, Inc., Astrazeneca LP, Novartis Consumer Health, Inc., Takeda Pharmaceutical Company Limited, Novartis Pharmaceuticals Corporation, The Procter & Gamble Company, Astrazeneca Pharmaceuticals LP, Novartis Institutes For Biomedical Research, Inc., Merck & Co., Inc., D/B/A Merck, Sharp & Dohme Corporation, Novartis Corporation, The Procter & Gamble Manufacturing Company, Takeda Development Center Americas, Inc. F/K/A Takeda Global Research & Development Center, Inc. and Takeda Pharmaceuticals America, Inc. |
| 1:2019cv04488 |
| July 2, 2019 |
| US District Court for the Northern District of Illinois |
| Robert M Dow |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 29, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| ELECTRONIC Acknowledgement of case transferred to the District of New Jersey [LIVE] as case 2:19-cv-16011, filed 07/29/2019. (jjr, ) |
| Filing 16 TRANSFERRED to the U.S.D.C. for the District of New Jersey the electronic record. (jjr, ) |
| Filing 14 MINUTE entry before the Honorable Robert M. Dow, Jr:Telephonic motion hearing held. Defendants' motion to stay proceedings pending transfer to MDL #10 is granted. Mailed notice (cdh, ) |
| Filing 13 MINUTE entry before the Honorable Robert M. Dow, Jr: Counsel that would like to participate by telephone may do so by using the Court's toll-free call-in number 877-336-1829 and conference access code 6963747. Mailed notice (cdh, ) |
| Filing 15 CONDITIONAL TRANSFER ORDER from MDL Panel transferring case to U.S.D.C. for the District of New Jersey. Mailed notice. (jjr, ) |
| ***Civil Case Terminated pursuant to MDL 2789 Conditional Transfer Order filed 07/18/2019. (jjr, ) |
| Filing 12 ATTORNEY Appearance for Defendant The Procter & Gamble Company by Kerry Carson Green (Green, Kerry) |
| Filing 11 ATTORNEY Appearance for Defendant The Procter & Gamble Company by Jeffrey Daniel Geoppinger (Geoppinger, Jeffrey) |
| Filing 10 NOTICE of Motion by Isaac J. Colunga for presentment of motion to stay #8 before Honorable Robert M. Dow Jr. on 7/24/2019 at 09:15 AM. (Colunga, Isaac) |
| Filing 9 MINUTE entry before the Honorable Robert M. Dow, Jr: Counsel is reminded that pursuant to Local Rule 5.3(b) all motions must be accompanied by a notice of motion (filed separately) setting the motion for presentment withing 14 days of the filing of the motion before the assigned judge or the motion may be stricken. Counsel should refer to the Court's website and case procedures for further information. Mailed notice (cdh, ) |
| Filing 8 MOTION by Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc., D/B/A Merck, Sharp & Dohme Corporation to stay (Attachments: #1 Exhibit A, #2 Exhibit B)(Maly, Heather) |
| Filing 7 ATTORNEY Appearance for Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc., D/B/A Merck, Sharp & Dohme Corporation by Isaac J. Colunga (Colunga, Isaac) |
| Filing 6 NOTICE TO THE PARTIES - The Court is participating in the Mandatory Initial Discovery Pilot (MIDP). The key features and deadlines are set forth in this Notice which includes a link to the (MIDP) Standing Order and a Checklist for use by the parties. In cases subject to the pilot, all parties must respond to the mandatory initial discovery requests set forth in the Standing Order before initiating any further discovery in this case. Please note: The discovery obligations in the Standing Order supersede the disclosures required by Rule 26(a)(1). Any party seeking affirmative relief must serve a copy of the following documents (Notice of Mandatory Initial Discovery and the Standing Order) on each new party when the Complaint, Counterclaim, Crossclaim, or Third-Party Complaint is served. (cc, ) |
| Filing 5 MAILED Notice of Removal letter to counsel of record. (cc, ) |
| Filing 4 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Merck & Co., Inc., D/B/A Merck, Sharp & Dohme Corporation (Maly, Heather) |
| Filing 3 NOTIFICATION of Affiliates pursuant to Local Rule 3.2 by Astrazeneca LP, Astrazeneca Pharmaceuticals LP (Maly, Heather) |
| Filing 2 ATTORNEY Appearance for Defendants Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc., D/B/A Merck, Sharp & Dohme Corporation by Heather Lynn Maly (Maly, Heather) |
| Filing 1 NOTICE of Removal from Circuit Court of Cook County, Illinois, case number (2019L006039) filed by Astrazeneca LP, Astrazeneca Pharmaceuticals LP, Merck & Co., Inc., D/B/A Merck, Sharp & Dohme Corporation Filing fee $ 400, receipt number 0752-15993153. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet Civil Cover Sheet)(Maly, Heather) |
| CASE ASSIGNED to the Honorable Robert M. Dow, Jr. Designated as Magistrate Judge the Honorable Jeffrey Cummings. Case assignment: Random assignment. (ec, ) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
